Regulators of necroptotic signaling, including RIPK1, RIPK3, and MLKL, have demonstrated prognostic relevance in diverse tumor entities (Yuan, Amin & Ofengeim, 2019; Martens et al., 2021; Zang et al., 2022). Here, RIPK1 is linked to neoplasm.